Drug Discovery

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker

NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Remembering the achievements in the short but successful life of insulin co-developer and Nobel Prize laureate Frederick Banting.

Contribute to our special feature celebrating the future of pharma.

How one company is hoping to create a functional cure for HIV

AI is generating new drug discovery solutions for a rapidly changing industry

The use of AI in small molecules drug discovery is driving the sector in big ways – but there are big challenges too. Here are five steps to success

How researchers are using mRNA to help untangle Alzheimer’s disease.